Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience

Journal of Gastrointestinal Oncology

Jeannelyn Estrella²  Aziz Tabash²  Jaffer A. Ajani¹  Jane E. Rogers¹  Catherine E. Devine¹  Prajnan Das¹  Aurelio Matamoros¹  Quan D. Lin²  Yazan Fahmawi²  Brian D. Badgwell¹  Humaid O. Al-Shamsi²  Mariela A. Blum²  Tara Sagebiel¹  Ibrahim Dahbour²  Jeannette Elizabeth Mares² 

[1] Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 3Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 5Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 3Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 5Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 3Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 5Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

关键词: Gastric cancer;    human epidermal growth factor receptor 2 (HER2);    trastuzumab;   

DOI  :  10.21037/jgo.2016.06.16

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown